{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:41:20Z","timestamp":1790174480533,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"RTD","award":["QLK-CT-2002-01001"],"award-info":[{"award-number":["QLK-CT-2002-01001"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 617"],"award-info":[{"award-number":["SFB 617"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GU0824"],"award-info":[{"award-number":["01GU0824"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else-Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"crossref","award":["2011_A140"],"award-info":[{"award-number":["2011_A140"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.bbamem.2016.01.011","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T02:15:46Z","timestamp":1453256146000},"page":"971-979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis"],"prefix":"10.1016","volume":"1858","author":[{"given":"Klaus","family":"Brandenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Heinbockel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilmar","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Lohner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamem.2016.01.011_bb0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4331\/wjbc.v6.i3.71","article-title":"Lack of new antiinfective agents: passing into the pre-antibiotic age?","volume":"6","author":"Brandenburg","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nbt.2779","article-title":"Collateral damage","volume":"32","author":"Hancock","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaad.2004.08.026","article-title":"Antimicrobial peptides","volume":"52","author":"Izadpanah","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0161-5890(03)00162-7","article-title":"Antimicrobial peptides in defence of the oral and respiratory tracts","volume":"40","author":"Devine","year":"2003","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1871526510808030135","article-title":"The role of antimicrobial peptides in human skin and in skin infectious diseases","volume":"8","author":"Schittek","year":"2008","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0030","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/infdis\/167.6.1336","article-title":"Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli","volume":"167","author":"Evans","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0035","first-page":"39","article-title":"Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification","volume":"216","author":"Rietschel","year":"1996","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0040","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1038\/srep14292","article-title":"Lipoproteins\/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides","volume":"5","author":"Martinez de Tejada","year":"2015","journal-title":"Sci. Report."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jac\/41.2.163","article-title":"Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics","volume":"41","author":"Trautmann","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0050","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nchembio.1393","article-title":"Immune modulation by multifaceted cationic host defense (antimicrobial) peptides","volume":"9","author":"Hilchie","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1567-5769(02)00277-1","article-title":"A Limulus anti-LPS factor-derived peptide modulates cytokine gene expression and promotes resolution of bacterial acute infection in mice","volume":"3","author":"Vallespi","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00232-011-9343-0","article-title":"Antimicrobial peptides: successes, challenges and unanswered questions","volume":"239","author":"Wimley","year":"2011","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/1389557013406729","article-title":"Peptides neutralizing lipopolysaccharide \u2014 structure and function","volume":"1","author":"Pristovsek","year":"2001","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0070","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fimmu.2015.00404","article-title":"Antimicrobial peptides in human sepsis","volume":"6","author":"Martin","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0075","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0080","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1699-0463.1999.tb01499.x","article-title":"Lactoferrin: a multifunctional glycoprotein","volume":"107","author":"Vorland","year":"1999","journal-title":"APMIS"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0085","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1515\/BC.2001.152","article-title":"Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin","volume":"382","author":"Brandenburg","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1753425909106447","article-title":"Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells","volume":"16","author":"Gutsmann","year":"2010","journal-title":"Innate Immun."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/1047-8477(90)90093-R","article-title":"Phase diagram of lipid A from Salmonella minnesota and Escherichia coli rough mutant lipopolysaccharide","volume":"105","author":"Brandenburg","year":"1990","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0100","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1529\/biophysj.104.047944","article-title":"Temperature dependence of the binding of endotoxins to the polycationic peptides polymyxin B and its nonapeptide","volume":"88","author":"Brandenburg","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0105","first-page":"213","article-title":"Polymyxin B: an ode to an old antidote for endotoxic shock","volume":"1","author":"Bhor","year":"2005","journal-title":"Mol. Bio Syst."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1574-6968.2004.tb09482.x","article-title":"Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity","volume":"233","author":"Farnaud","year":"2004","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0115","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1021\/jm701600a","article-title":"Synthetic antimicrobial peptidomimetics with therapeutic potential","volume":"51","author":"Haug","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20041270","article-title":"Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide","volume":"385","author":"Andr\u00e4","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/187152110790886736","article-title":"Effective antimicrobial and anti-endotoxin activity of cationic peptides based on lactoferricin: a biophysical and microbiological study","volume":"9","author":"Brandenburg","year":"2010","journal-title":"Anti-Infect. Agents Med. Chem."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0130","doi-asserted-by":"crossref","first-page":"21266","DOI":"10.1074\/jbc.M110.195412","article-title":"Studies on lactoferricin-derived Escherichia coli membrane-active peptides reveal differences in the mechanism of N-acylated versus nonacylated peptides","volume":"286","author":"Zweytick","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0135","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.4049\/jimmunol.164.9.4804","article-title":"Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-\u03b1 production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock","volume":"164","author":"Dankesreiter","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1067\/msy.2000.108061","article-title":"Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor","volume":"128","author":"Weiss","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/sur.2006.7.45","article-title":"Comparison of endotoxin antagonism of linear and cyclized peptides derived from Limulus anti-lipopolysaccharide factor","volume":"7","author":"Leslie","year":"2006","journal-title":"Surg. Infect."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0150","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.intimp.2008.01.015","article-title":"A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo","volume":"8","author":"Ren","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0155","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.bcp.2004.05.054","article-title":"Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide","volume":"68","author":"Andr\u00e4","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070279","article-title":"Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis","volume":"406","author":"Andr\u00e4","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0165","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1128\/AAC.00534-10","article-title":"New antiseptic peptides to protect against endotoxin-mediated shock","volume":"54","author":"Gutsmann","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0170","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1128\/AAC.02066-12","article-title":"Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors","volume":"57","author":"Heinbockel","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0175","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1096\/fasebj.8.2.8119492","article-title":"Bacterial endotoxin: molecular relationships of structure to activity and function","volume":"8","author":"Rietschel","year":"1994","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0180","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1016\/j.bpj.2011.04.041","article-title":"Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides","volume":"100","author":"Kaconis","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1432-1033.1989.tb14676.x","article-title":"Characterization of the lipid A component of genuine smooth-form lipopolysaccharide","volume":"180","author":"Jiao","year":"1989","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/cc11220","article-title":"Antimicrobial peptides and their potential application in inflammation and sepsis","volume":"16","author":"Schuerholz","year":"2012","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0195","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/cc11920","article-title":"The anti-inflammatory effect of the synthetic antimicrobial peptide 19\u20132.5 in a murine sepsis model: a prospective randomized study","volume":"17","author":"Schuerholz","year":"2013","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0200","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/187152109789760171","article-title":"Current understanding of polymyxin B applications in bacteraemia\/sepsis therapy prevention: clinical, pharmaceutical, structural and mechanistic aspects","volume":"8","author":"Garidel","year":"2009","journal-title":"Anti-Infect. Agents Med. Chem."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0205","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/00003246-199908000-00039","article-title":"Clinical Gram-positive sepsis: does it fundamentally differ from Gram-negative bacterial sepsis?","volume":"27","author":"Opal","year":"1999","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0210","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.165.3.1486","article-title":"Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin","volume":"165","author":"Wang","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0215","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.bbamem.2007.05.001","article-title":"Biophysical analysis of the interaction of granulysin-derived peptides with enterobacterial endotoxins","volume":"1768","author":"Chen","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0220","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1128\/AAC.48.5.1593-1599.2004","article-title":"Biophysical characterization of endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-lysin","volume":"48","author":"Andr\u00e4","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BJ20091607","article-title":"Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis","volume":"427","author":"Hammer","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0230","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.bbamem.2014.07.006","article-title":"Galleria mellonella native and analogue peptides Gm1 and DeltaGm1. I) Biophysical characterization of the interaction mechanisms with bacterial model membranes","volume":"1838","author":"Correa","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0235","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.bbamem.2014.07.005","article-title":"Galleria mellonella native and analogue peptides Gm1 and DeltaGm1. II) Anti-bacterial and anti-endotoxic effects","volume":"1838","author":"Correa","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0240","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2008.08.017","article-title":"Lipopolysaccharide neutralization by the antibacterial peptide CM4","volume":"596","author":"Lin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0245","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.peptides.2005.09.016","article-title":"Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application","volume":"27","author":"Nell","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0250","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1128\/AAC.01583-05","article-title":"In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37","volume":"50","author":"Sigurdardottir","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0255","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.bbamem.2009.02.020","article-title":"Cell specificity, anti-inflammatory activity, and plausible bactericidal mechanism of designed Trp-rich model antimicrobial peptides","volume":"1788","author":"Park","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0260","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1742-4658.2006.05589.x","article-title":"Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent antibacterial and lipopolysaccharide-neutralizing activities","volume":"274","author":"Bommineni","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0265","first-page":"972","article-title":"Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18\/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues","volume":"9","author":"Nagaoka","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0270","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1753425914535957","article-title":"Mechanism of Hbgamma-35-induced an increase in the activation of the human immune system by endotoxins","volume":"21","author":"Heinbockel","year":"2015","journal-title":"Innate Immun."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0275","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1021\/bi800450f","article-title":"Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides","volume":"47","author":"Rosenfeld","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0280","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev.iy.13.040195.002253","article-title":"Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin","volume":"13","author":"Ulevitch","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0285","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/1753425912473851","article-title":"Cellular distribution of lipid A and LPS R595 after in vitro application to isolated human monocytes by freeze-fracture replica immunogold-labelling","volume":"19","author":"Richter","year":"2013","journal-title":"Innate Immun."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0290","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/la503267k","article-title":"Characterization of the aggregates formed by various bacterial lipopolysaccharides in solution and upon interaction with antimicrobial peptides","volume":"31","author":"Bello","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.bbamem.2016.01.011_bb0295","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/157340605774598180","article-title":"Investigation into the interaction of the phosphoporin PhoE with outer membrane lipids: physicochemical characterization and biological activity","volume":"1","author":"Andr\u00e4","year":"2005","journal-title":"Med. Chem."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0300","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1046\/j.1432-1327.2002.02820.x","article-title":"Lipopolysaccharideride regions involved in the activation of Escherichia coli outer membrane protease OmpT","volume":"269","author":"Kramer","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0305","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1021\/ja067419v","article-title":"The acyl group as the central element of the structural organization of antimicrobial lipopeptide","volume":"129","author":"Japelj","year":"2007","journal-title":"J. Am. Chem. Soc."},{"issue":"2\u20136","key":"10.1016\/j.bbamem.2016.01.011_bb0310","first-page":"S6","article-title":"Sepsis and evolution of the innate immune response","volume":"29","author":"Beutler","year":"2001","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0315","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1073\/pnas.76.11.5939","article-title":"Galactosamine-induced sensitization to the lethal effects of endotoxin","volume":"76","author":"Galanos","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamem.2016.01.011_bb0325","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jms.611","article-title":"Lipid A components from Pseudomonas aeruginosa PAO1 (serotype O5) and mutant strains investigated by electrospray ionization ion-trap mass spectrometry","volume":"39","author":"Bedoux","year":"2004","journal-title":"J. Mass Spectrom."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273616300013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273616300013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T01:20:14Z","timestamp":1617326414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005273616300013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0005273616300013"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamem.2016.01.011","relation":{},"ISSN":["0005-2736"],"issn-type":[{"value":"0005-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Biomembranes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamem.2016.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}